Harmonization of Drug Regulation in Canada

Download
328.71 KB18 pages

Harmonizing standards on drug regulation among countries makes sense since it can reduce the workload on individual regulatory agencies and allow them to draw on each other’s strengths.

However, harmonization must be to the highest standards, protect safety, ensure that only drugs that are truly effective are marketed, and protect a country’s ability to act independently. This report looks at the history of harmonization in general and, in particular, examines what has been happening in Canada. It finds that the evidence to date suggests that harmonization in Canada has been to a lower standard.

Office:

National Office

Project:

Issues:

Supporting Materials

We’re fighting for change and your donation helps!

The CCPA is Canada’s leading progressive policy research institute. Donors provide core funding for our work. We provide tax receipts.

WAYS TO GIVE

Contact Us

Have questions? Send us a message, or find the office closest to you.